🔗 Share this article

Texas Attorney General Paxton is taking legal action against the producers of Tylenol, alleging the companies hid potential risks that the drug posed to pediatric cognitive development.

The lawsuit comes thirty days after Donald Trump advocated an unsubstantiated connection between using acetaminophen - alternatively called acetaminophen - during pregnancy and autism in young ones.

The attorney general is suing J&J, which once produced the drug, the only pain reliever approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he stated they "misled consumers by profiting off of discomfort and promoting medication without regard for the potential hazards."

Kenvue asserts there is insufficient reliable data linking acetaminophen to autism.

"These manufacturers misled for generations, deliberately risking millions to boost earnings," Paxton, from the Republican party, declared.

The company stated officially that it was "very worried by the dissemination of inaccurate information on the safety of acetaminophen and the potential impact that could have on the health of US mothers and children."

On its website, the company also stated it had "continuously evaluated the relevant science and there is insufficient valid information that indicates a proven link between taking acetaminophen and autism."

Groups acting on behalf of physicians and healthcare providers agree.

The leading OB-GYN organization has stated acetaminophen - the primary component in acetaminophen - is a restricted selection for expectant mothers to treat discomfort and elevated temperature, which can pose significant medical dangers if not addressed.

"In more than two decades of investigation on the utilization of paracetamol in gestation, not a single reputable study has conclusively proven that the usage of acetaminophen in any stage of gestation leads to neurodevelopmental disorders in young ones," the association commented.

This legal action mentions latest statements from the former administration in claiming the medication is potentially dangerous.

Last month, Trump caused concern from medical authorities when he advised expectant mothers to "resist strongly" not to use acetaminophen when ill.

Federal regulators then published an announcement that physicians should think about restricting the usage of acetaminophen, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in young ones has remains unverified.

The Health Department head Kennedy, who oversees the FDA, had pledged in spring to conduct "comprehensive study program" that would establish the origin of autism spectrum disorder in a limited time.

But specialists cautioned that finding a sole reason of autism spectrum disorder - considered by experts to be the consequence of a complex mix of genetic and external influences - would not be simple.

Autism is a type of enduring cognitive variation and condition that impacts how individuals experience and interact with the surroundings, and is identified using physician assessments.

In his legal document, Paxton - who supports Trump who is seeking US Senate - alleges Kenvue and J&J "intentionally overlooked and sought to suppress the research" around acetaminophen and autism spectrum disorder.

The lawsuit aims to force the firms "remove any commercial messaging" that states Tylenol is secure for expectant mothers.

The court case mirrors the complaints of a group of parents of minors with autism spectrum disorder and ADHD who sued the producers of acetaminophen in recently.

Judicial authorities threw out the case, declaring studies from the family's specialists was not conclusive.